{"schema_version":"secwatch.filing_event.v1","accession":"0001818331-22-000068","form_type":"8-K","ticker":"WGS","cik":"0001818331","company_name":"GeneDx Holdings Corp.","filed_at":"2022-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.189839+00:00","generated_at":"2026-06-24T00:01:30.174347+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Sema4 Q2 revenue $36.2M, net loss $85.7M; exits somatic testing, cuts 13% workforce; founder Schadt resigns","bullets":["Q2 total revenue $36.2M (or $66.3M excluding $30.1M prior-period adjustments); net loss $85.7M; adjusted net loss $72.9M.","Exiting somatic tumor testing (<1% revenue, ~$35M annual expense); eliminating ~250 positions (~13% workforce), cumulative 30% role reduction.","Founder Eric Schadt resigns as President, Chief R&D Officer, and board member; Matthew Davis (ex-Invitae) named Chief Technology & Product Officer.","FY2022 revenue guidance $245-255M; adj. gross margin 4-9% (incl. $24M prior-period adjustment); expects >$165M cash by year-end."],"urls":{"canonical":"https://secwatch.observer/filing/0001818331-22-000068","json":"https://secwatch.observer/filing/0001818331-22-000068.json","markdown":"https://secwatch.observer/filing/0001818331-22-000068.md","text":"https://secwatch.observer/filing/0001818331-22-000068.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818331/000181833122000068/0001818331-22-000068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818331/000181833122000068/smfr-20220815.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T00:01:30.174347+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}